Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:735-741
Published online before print October 7, 2002, doi: 10.1161/01.HYP.0000036452.28493.74
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/735    most recent
01.HYP.0000036452.28493.74v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cervenka, L.
Right arrow Articles by Navar, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cervenka, L.
Right arrow Articles by Navar, L. G.
Related Collections
Right arrow Hypertension - basic studies

(Hypertension. 2002;40:735.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Essential Role of AT1A Receptor in the Development of 2K1C Hypertension

Ludek Cervenka; Vladislav Horácek; Ivana Vanecková; Jaroslav A. Hubácek; Michael I. Oliverio; Thomas M. Coffman; L. Gabriel Navar

From the Center for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine (L.C.), V.H., I.V., J.A.H.), Prague, Czech Republic; Department of Medicine, Duke University, Winston-Salem, and Durham Veterans Affairs Medical Center (M.I.O., T.M.C.), Durham, NC; Department of Physiology, Tulane University School of Medicine (L.G.N.), New Orleans, La; and Department of Physiology, Second Medical Faculty, Charles University (L.C.), Prague, Czech Republic.

Correspondence to Ludek Cervenka, MD, PhD, Center for Experimental Cardiovascular Research, Institute for Clinical and Experimental Medicine, 1958/9 Videcská, CZ-140 21 Prague 4, Czech Republic. E-mail luce{at}medicon.cz

The aims of this study were to delineate the relative contribution of angiotensin II (ANG II) subtype 1A (AT1A) and 1B (AT1B) receptors to the development of two-kidney, one-clip (2K1C) Goldblatt hypertension in mice, to examine if increased nitric oxide synthase (NOS) activity counteracts the vasoconstrictor influences of ANG II in 2K1C hypertensive mice, and to determine the role of ANG II type 2 (AT2) receptors in 2K1C hypertension in mice. AT1A ANG II receptor knockout (AT1A-/-) and wild-type (AT1A+/+) mice underwent clipping of the right renal artery. Systolic blood pressure (SBP) was significantly lower in AT1A-/- compared with AT1A+/+ mice, and neither clip placement nor AT2 receptor blockade with PD 123319 (PD) altered SBP in AT1A-/- mice. A significant and sustained rise in SBP from 119±5 to 163±6 mm Hg was observed in the 2K1C AT1A+/+ mice from day 10 to day 26. Chronic PD infusion did not alter the course of hypertension in 2K1C/AT1A+/+. Acute PD infusion did not alter mean arterial pressure (MAP) in AT1A+/+, PD/AT1A+/+, 2K1C/AT1A+/+, PD/2K1C/AT1A+/+, AT1A-/-, PD/AT1A-/-, and PD/2K1C/AT1A-/- mice compared with basal levels. In contrast, acute PD infusion caused significant increases in MAP in 2K1C/AT1A-/- mice. The subsequent acute NOS inhibition caused greater increases in MAP in 2K1C/AT1A+/+ and PD/2K1C/AT1A+/+ mice than in AT1A+/+ and PD/AT1A+/+ mice. These results support the essential role of AT1A receptors in mediating 2K1C hypertension and support the hypothesis that augmented NO production serves as a counteracting system in this model of hypertension.


Key Words: mice • receptors, angiotensin II • hypertension, renovascular • nitric oxide synthase • nitric oxide




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. M. Gwathmey, H. A. Shaltout, K. D. Pendergrass, N. T. Pirro, J. P. Figueroa, J. C. Rose, D. I. Diz, and M. C. Chappell
Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production
Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1484 - F1493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. Griol-Charhbili, L. Sabbah, J. Colucci, M.-P. Vincent, V. Baudrie, D. Laude, J.-L. Elghozi, P. Bruneval, N. Picard, P. Meneton, et al.
Tissue kallikrein deficiency and renovascular hypertension in the mouse
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1385 - R1391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. R. Borges, H. C. Salgado, C. A. A. Silva, M. A. Rossi, C. M. Prado, and R. Fazan Jr.
Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1904 - R1913.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Gonzalez-Villalobos, D. M. Seth, R. Satou, H. Horton, N. Ohashi, K. Miyata, A. Katsurada, D. V. Tran, H. Kobori, and L. G. Navar
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F772 - F779.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff
Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease
Hypertension, May 1, 2008; 51(5): 1379 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Stegbauer, Y. Kuczka, O. Vonend, I. Quack, L. Sellin, A. Patzak, A. Steege, K. Langnaese, and L. C. Rump
Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R421 - R428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. C. Li and J. L. Zhuo
In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F293 - F302.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo
Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis
Hypertension, February 1, 2008; 51(2): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart
Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3072 - H3079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Wagenseil, R. H. Knutsen, D. Y. Li, and R. P. Mecham
Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H574 - H582.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Nuyt and M. Szyf
Developmental Programming Through Epigenetic Changes
Circ. Res., March 2, 2007; 100(4): 452 - 455.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Helle, O. B. Vagnes, and B. M. Iversen
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M.P. Arruda, V. A. Peotta, S. S. Meyrelles, and E. C. Vasquez
Evaluation of Vascular Function in Apolipoprotein E Knockout Mice With Angiotensin-Dependent Renovascular Hypertension
Hypertension, October 1, 2005; 46(4): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. D. Garovic and S. C. Textor
Renovascular Hypertension and Ischemic Nephropathy
Circulation, August 30, 2005; 112(9): 1362 - 1374.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, O. B. Vagnes, and B. M. Iversen
The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Hiyoshi, K. Yayama, M. Takano, and H. Okamoto
Angiotensin Type 2 Receptor-Mediated Phosphorylation of eNOS in the Aortas of Mice With 2-Kidney, 1-Clip Hypertension
Hypertension, May 1, 2005; 45(5): 967 - 973.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. Sun, X. Wang, C. E. Wood, and J. R. Cade
Genetic AT1A receptor deficiency attenuates cold-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R433 - R439.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. P. Printz
The Confluence of Population Genetics with Molecular Pharmacology at the Angiotensin II Receptor: Dawn of a New Era or Just a New Wrinkle?
Mol. Pharmacol., March 1, 2004; 65(3): 488 - 491.
[Full Text] [PDF]